« Previous
Next »
Diabetes Research and Clinical Practice
Volume 65, Issue 2
, Pages 167-173
, August 2004
Elevation of urinary βig-h3, transforming growth factor-β-induced protein in patients with type 2 diabetes and nephropathy
References
- . Human transforming growth factor alpha; precursor structure and expression in E coli. Cell. 1984;38:287–297
- . Transforming growth factor-β in disease, the dark side of tissue repair. J. Clin. Invest. 1992;90:1–7
- . Transforming growth factor-β in tissue fibrosis. N. Engl. J. Med. 1994;331:1286–1292
- . Hyperglycemia and diabetic kidney disease; the case for transforming growth factor-β as a key mediator. Diabetes. 1995;44:1139–1146
- . Urinary transforming growth factor-β1 and α1-macroglobulin in children and adolescents with type 1 diabetes. Diabetes Care. 2000;23:664–668
- . Urinary measurement of transforming growth factor-β and type IV collagen as new marker of renal injury; application in diabetic nephropathy. Clin. Chem. 1998;44:950–956
- Increased renal production of transforming growth factor-β1 in patients with type II diabetes. Diabetes. 1997;46:854–859
- . Renal processing of albumin in diabetes and hypertension in rats. Possible role of TGF-β1. Am. J. Nephrol. 2003;23:61–70
- . Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy. Kidney Int. 2000;57:1002–1014
- . cDNA cloning and sequence analysis of βig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-β. DNA Cell Biol. 1992;11:511–522
- Expression of TGF-β-induced matrix protein βig-h3 is up-regulated in the diabetic rat kidney and human proximal tubular epithelial cells treated with high glucose. Kidney Int. 2003;64:1012–1021
- Renal expression of transforming growth factor-β inducible gene-h3 (βig-h3) in normal and diabetic rats. Kidney Int. 1998;54:1052–1062
- . Perspectives in diabetes; the need for early predictors of diabetic nephropathy risk. Is albumin excretion rate sufficient?. Diabetes. 2000;49:1399–1408
- . Identification of motifs for cell adhesion within the repeated domains of transforming growth factor-β-induced gene, βig-h3. J. Biol. Chem. 2000;275:30907–30915
- . TGF-β in diabetic kidney disease; role of novel signaling pathways. Cytokine Growth Factor Rev. 2000;11:115–123
-
.
Transforming growth factor-β contributes to progressive diabetic nephropathy.
Proc. Natl. Acad. Sci. U.S.A. 2000;97:7667–7669
- . Hyperglycemia and diabetic kidney disease: the case for transforming growth factor-β as a key mediator. Diabetes. 1995;44:1139–1146
-
.
Urinary excretion of TGF-β1, PDGF and fibronectin in insulin-dependent diabetes mellitus patients.
Kidney Int. 1997;62:S195–S197
-
.
Transforming growth factor beta activity in urine of patients with type 2 diabetes and diabetic nephropathy.
Braz. J. Med. Biol. Res. 1999;32:1526–1528
- TGF-β-induced protein, βig-h3 is up-regulated by high glucose in vascular smooth muscle cells. J. Cell Biochem. 2003;88:774–782
PII: S0168-8227(04)00040-3
doi: 10.1016/j.diabres.2004.01.007
© 2004 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Diabetes Research and Clinical Practice
Volume 65, Issue 2
, Pages 167-173
, August 2004
